Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Adamis Pharmaceuticl (ADMP)

Adamis Pharmaceuticl (ADMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Adamis Pharmaceuticals (ADMP) Reports Q3 Loss, Misses Revenue Estimates

Adamis (ADMP) delivered earnings and revenue surprises of -83.33% and -9.88%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

ADMP : 0.88 (-5.38%)
Adamis: 3Q Earnings Snapshot

SAN DIEGO (AP) _ Adamis Pharmaceuticals Corp. (ADMP) on Tuesday reported a loss of $7 million in its third quarter.

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Announces Third Quarter 2019 Financial Results and Business Update

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the third quarter ended September 30, 2019 and provided a business update.

ADMP : 0.88 (-5.38%)
Implied Volatility Surging for Adamis Pharmaceuticals (ADMP) Stock Options

Investors need to pay close attention to Adamis Pharmaceuticals (ADMP) stock based on the movements in the options market lately.

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Schedules Third Quarter 2019 Earnings Conference Call and Business Update

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis") announced today that it will host an investor conference call on Tuesday, November 12, 2019 at 2:00 pm Pacific Time to discuss its financial...

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Provides Regulatory Update for Its Higher Dose Naloxone Pre-Filled Syringe

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis") today announced that as of the close of business today, Adamis has not received any notice of action from the U.S. Food and Drug Administration...

ADMP : 0.88 (-5.38%)
Will Adamis Pharmaceuticals (ADMP) Report Negative Q3 Earnings? What You Should Know

Adamis (ADMP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Announces Presentation of ZIMHI data at IHV Scientific Meeting

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis") announced today the presentation of data pertaining to its investigational high dose naloxone product (ZIMHI) at the Institute of Human Virology...

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Announces Commercial Partnership with Emerge Health for SYMJEPI(R) in Australia and New Zealand

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that it has entered into an exclusive distribution and commercialization agreement with Emerge Health Pty ("Emerge") to register and commercialize...

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Announces Presentation Pertaining to Its High Dose Naloxone Product Candidate at IHV Scientific Meeting

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that Dr. Ronald Moss, Chief Medical Officer, will be presenting data on October 4, 2019, pertaining to the company's investigational high...

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Provides Update for Naloxone Product Candidate

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today the completion of pharmacokinetic (PK) studies comparing its naloxone injection product candidate, ZIMHI(naloxone) Injection, to a generic...

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Provides Launch and Marketing Update for SYMJEPI

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today provided a progress report and marketing update on the U.S. launch of SYMJEPI (epinephrine) 0.3 mg and 0.15 mg Injections.

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Announces Appointment of New Members to Its Board of Directors

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced the appointment of Howard C. Birndorf and Roshawn Blunt to its Board of Directors.

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Strengthens Patent Portfolio for its U.S. Compounding Subsidiary

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for a patent application (U.S. Patent...

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals (ADMP) Reports Q2 Loss, Misses Revenue Estimates

Adamis (ADMP) delivered earnings and revenue surprises of -33.33% and -1.00%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

ADMP : 0.88 (-5.38%)
Adamis: 2Q Earnings Snapshot

SAN DIEGO (AP) _ Adamis Pharmaceuticals Corp. (ADMP) on Thursday reported a loss of $7.7 million in its second quarter.

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Announces Second Quarter 2019 Financial Results and Business Update

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced financial results for the second quarter ended June 30, 2019 and provided a business update.

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Schedules Second Quarter 2019 Earnings Conference Call and Business Update

Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) ("Adamis"), a specialty biopharmaceutical company primarily focused on developing and commercializing products in the therapeutic areas of allergy, respiratory...

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

Adamis (ADMP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ADMP : 0.88 (-5.38%)
Adamis Pharmaceuticals Announces Pricing of Public Offering of Common Stock and Warrants

Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including respiratory disease,...

ADMP : 0.88 (-5.38%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +0.13 , AIZ -0.33 , SBAC -0.85 , SO -0.32 , WELL +0.39
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar